Frank Carlson Library

In the biggest case of her career, attorney Kate Sullivan has been appointed lead counsel to take on Mason Pharmaceutical in a claim involving an allegedly dangerous new drug. She hires former Army Ranger turned private investigator Landon James to do some digging. When a whistleblower is found dead, it's clear the stakes are higher than ever. Will this case prove deadly for Kate?

Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?...

Samantha, the daughter of Luke Vaughn, a high-powered Houston lawyer who's relocated to the small town of San Marcos, Tex., becomes ill after participating in a trial for a new antibiotic. The drug is produced by an evil pharmaceutical magnate, Dr. Alfred Kingsbury, whose lust for obscene profits leads him to cartoonish acts of villainy. When Luke learns what caused his daughter's liver failure, he takes on Kingsbury's company in a product liability...

Three stories about the world of opioids collide: a drug trafficker arranges a multi-cartel Fentanyl smuggling operation between Canada and the U.S., an architect recovering from an OxyContin addiction tracks down the truth behind her son's involvement with narcotics, and a university professor battles unexpected revelations about his research employer, a drug company with deep government influence bringing a new non-addictive painkiller to market....

"The blistering inside story of a startup that made millions pushing opioids-until its cutthroat tactics were exposed and its executives put behind bars John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It was the 2000s, and opioids were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention...